GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lushang Freda Pharmaceutical Co 600223.SS · CNY

Real Estate · Shanghai · 🇨🇳 China

Compare

5.29

-0.75%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥3.65bn

FY2016FY2025

Net income

CN¥187.8m

FY2016FY2025

Free cash flow

CN¥165.8m

FY2016FY2025

Shareholders' equity

CN¥4.23bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥3.65bnCN¥3.98bnCN¥4.58bnCN¥12.95bnCN¥12.36bnCN¥13.62bnCN¥10.29bnCN¥8.82bnCN¥8.29bnCN¥7.65bn
Research and developmentCN¥161.7mCN¥166.8mCN¥153.4mCN¥133.9mCN¥118.8mCN¥77.2mCN¥46.1mCN¥30.1mCN¥24.2m—
Operating incomeCN¥208.2mCN¥337.8mCN¥419.4mCN¥310.8mCN¥677.7mCN¥875.4mCN¥574.2mCN¥471.1mCN¥349.3mCN¥223.9m
Net incomeCN¥187.8mCN¥243.5mCN¥303.4mCN¥45.5mCN¥361.9mCN¥638.7mCN¥344.5mCN¥162.1mCN¥128.1mCN¥92.4m
Diluted earnings per share0.180.240.300.040.330.630.330.150.130.10

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥5.86bnCN¥6.00bnCN¥7.82bnCN¥58.47bnCN¥61.42bnCN¥61.50bnCN¥56.02bnCN¥48.88bnCN¥43.39bnCN¥42.53bn
Cash and short-term investments—CN¥2.95bnCN¥1.73bnCN¥4.32bnCN¥5.14bnCN¥5.07bnCN¥3.63bnCN¥3.83bnCN¥2.56bnCN¥4.24bn
Total liabilitiesCN¥910.1mCN¥1.21bnCN¥3.14bnCN¥52.91bnCN¥54.92bnCN¥54.98bnCN¥51.32bnCN¥45.99bnCN¥40.77bnCN¥39.98bn
DebtCN¥6.0mCN¥264.2mCN¥2.18bnCN¥7.73bnCN¥9.29bnCN¥11.47bnCN¥10.67bnCN¥9.60bnCN¥10.11bnCN¥11.79bn
Shareholders' equityCN¥4.23bnCN¥4.10bnCN¥4.01bnCN¥3.72bnCN¥4.73bnCN¥4.08bnCN¥2.74bnCN¥2.44bnCN¥2.33bnCN¥2.23bn
Shares outstanding1,017m1,015m1,017m1,017m1,105m1,018m1,038m1,057m981m906m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥276.2mCN¥228.7mCN¥536.8mCN¥998.1mCN¥6.85bnCN¥4.45bn−CN¥3.31bnCN¥2.10bnCN¥1.56bn−CN¥2.47bn
Capital spending−CN¥110.4m−CN¥157.2m−CN¥211.4m−CN¥166.1m−CN¥281.5m−CN¥157.1m−CN¥60.2m−CN¥33.7m−CN¥23.0m−CN¥25.4m
Free cash flowCN¥165.8mCN¥71.4mCN¥325.5mCN¥832.0mCN¥6.57bnCN¥4.29bn−CN¥3.37bnCN¥2.06bnCN¥1.53bn−CN¥2.49bn
Dividends paid−CN¥65.2m−CN¥183.6m−CN¥488.0m−CN¥111.0m−CN¥201.8m−CN¥110.1m−CN¥50.0m−CN¥738.3m−CN¥635.5m−CN¥630.6m

Latest quarters

By quarter end

Sept 2026Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024
RevenueCN¥865.2mCN¥1.01bnCN¥900.4mCN¥1.05bnCN¥807.3mCN¥913.5mCN¥876.1mCN¥1.18bn
Operating incomeCN¥33.6mCN¥62.7mCN¥31.0mCN¥67.1mCN¥11.2mCN¥83.7mCN¥71.2mCN¥95.8m
Net incomeCN¥29.3mCN¥49.9mCN¥31.9mCN¥46.0mCN¥33.8mCN¥57.3mCN¥50.7mCN¥72.4m
Diluted earnings per share0.030.050.030.050.030.060.050.07
Cash from operations————CN¥19.0mCN¥136.0m−CN¥117.0m—
Capital spending−CN¥37.0m−CN¥15.0m−CN¥16.0m−CN¥29.0m−CN¥25.0m−CN¥23.0m−CN¥31.0m−CN¥46.0m
Free cash flow————−CN¥6.0mCN¥113.0m−CN¥148.0m—
Total assetsCN¥5.76bnCN¥5.94bnCN¥5.93bnCN¥5.86bnCN¥5.83bnCN¥6.04bnCN¥6.04bnCN¥6.00bn
Cash and short-term investments————CN¥2.75bnCN¥2.95bnCN¥2.84bnCN¥2.95bn
DebtCN¥5.5mCN¥5.5mCN¥6.0mCN¥6.0mCN¥197.6mCN¥230.1mCN¥263.0mCN¥256.7m
Shareholders' equityCN¥4.29bnCN¥4.26bnCN¥4.26bnCN¥4.23bnCN¥4.19bnCN¥4.15bnCN¥4.16bnCN¥4.10bn

Financial ratios

Data as of 10 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin8.0%5.4%5.0%4.4%5.2%5.6%
Net margin5.1%6.1%6.6%0.4%2.9%4.7%
Return on equity4.4%5.9%7.6%1.2%7.7%15.7%
Return on assets3.2%4.1%3.9%0.1%0.6%1.0%
Free cash flow yield6.5%6.5%12.6%19.6%110.7%77.6%
Revenue growth-8.3%-13.0%-64.6%4.8%-9.2%32.3%
Earnings growth-22.9%-19.7%567.4%-87.4%-43.3%85.4%
Current ratio4.71x3.75x2.49x1.10x1.15x1.17x
Debt to equity0.00x0.06x0.34x1.21x1.47x2.14x
Equity ratio72.3%68.4%51.4%6.4%7.7%6.6%
Interest coverage49.78x8.80x2.23x1.40x4.98x7.54x
R&D as a share of sales4.4%4.2%3.3%1.0%1.0%0.6%
Buybacks as a share of market value-0.2%0.2%0.0%8.0%-8.6%1.9%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-34.4%-23.1%-4.6%
Operating income-12.5%-25.0%-2.7%
Net income60.4%-21.7%5.3%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin7.2%5.1%5.5%5.1%
Net margin5.6%3.1%3.5%2.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings39.931.532.3236.840.513.625.420.129.653.3
Price to sales2.01.92.10.81.20.60.80.40.50.6

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 15 Jul 2026.

FY2026FY2025FY2024FY2022FY2021FY2020FY2019FY2004
Paid in the year0.0570.060.150.110.200.110.050.15
  • 1-to-1 reverse split · 21 Feb 2006
  • 13-for-10 split · 14 Jun 2000

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.